Please find below previous updates on the status of pan-Canadian Pharmaceutical Alliance drug negotiations.
2020
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2019
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2018
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2017
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2016
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 29
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2015
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of March 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
2014
As of December 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of November 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of October 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of September 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of August 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of July 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of June 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of May 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 30
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of April 1
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of February 28
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory
As of January 31
• Active drug product negotiations
• Complete and closed drug product negotiations
• No negotiations
• Product negotiations being considered by each province/territory